MyAverix Finance
TWO · Healthcare
Bioray Biotech Co., Ltd (7561)
Drug Manufacturers - Specialty & Generic
Bioray Biotech Co., Ltd (7561) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-22, reported market cap is $562.12M, P/E ratio is 17.43, net margin is 13.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 7561
Bioray Biotech Co., Ltd (7561) — FAQ
What is Bioray Biotech Co., Ltd's market cap?
Bioray Biotech Co., Ltd (7561) has a reported market cap of $562.12M (data as of 2026-05-22).
What is 7561's P/E ratio?
The price-to-earnings (P/E) ratio for Bioray Biotech Co., Ltd (7561) is 17.43 (data as of 2026-05-22).
Does Bioray Biotech Co., Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Bioray Biotech Co., Ltd (7561). Check the MyAverix Finance app for the latest dividend data.
What sector is Bioray Biotech Co., Ltd in?
Bioray Biotech Co., Ltd (7561) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 7561 listed on?
7561 is listed on TWO.
What is Bioray Biotech Co., Ltd's net margin?
Bioray Biotech Co., Ltd (7561) reports a net margin of 13.3% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.